Indication
Chromoblastomycosis
Chromoblastomycosis is a chronic, progressive granulomatous fungal infection of the cutaneous and subcutaneous tissues caused by traumatic transcutaneous inoculation of pigmented dematiaceous fungi, most commonly *Fonsecaea pedrosoi* or *Cladophialophora carrionii*. Read more about Chromoblastomycosis
8 drugs 8 manufacturers
Drugs that treat it
Common Chromoblastomycosis therapies.
KETOCONAZOLE
KETOCONAZOLE
KETOCONAZOLE
KETOCONAZOLE
KETOCONAZOLE
KETOCONAZOLE
KETOCONAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChromoblastomycosis is a chronic, progressive granulomatous fungal infection of the cutaneous and subcutaneous tissues caused by traumatic transcutaneous inoculation of pigmented dematiaceous fungi, most commonly *Fonsecaea pedrosoi* or *Cladophialophora carrionii*.
It predominantly affects outdoor and agricultural laborers in tropical and subtropical climates, typically manifesting on exposed areas such as the extremities.
Clinically, it begins as an indolent erythematous macule or papule that evolves over months to years into polymorphic verrucous plaques, nodular lesions, or cauliflower-like tumoral masses prone to ulceration, secondary bacterial infection, and scarring.
Pathophysiologically, the disease is defined by suppurative granulomatous inflammation and microabscess formation, with histopathologic visualization of characteristic thick-walled, chestnut-brown muriform cells (sclerotic bodies) within tissue.
- cdc.gov
Chromoblastomycosis is a chronic, progressive granulomatous fungal infection of the cutaneous and subcutaneous tissues caused by traumatic transcutaneous inoculation of pigmented dematiaceous fungi, most commonly *Fonsecaea pedrosoi* or *Cladophialophora carrionii* It predominantly affects outdoor and agricultural laborers in tropical and subtropical climates, typically manifesting on exposed areas such as the extremities
- nih.gov
Chromoblastomycosis is a chronic, progressive granulomatous fungal infection of the cutaneous and subcutaneous tissues caused by traumatic transcutaneous inoculation of pigmented dematiaceous fungi, most commonly *Fonsecaea pedrosoi* or *Cladophialophora carrionii* Clinically, it begins as an indolent erythematous macule or papule that evolves over months to years into polymorphic verrucous plaques, nodular lesions, or cauliflower-like tumoral masses prone to ulceration, secondary bacterial infe...
- nih.gov
Chromoblastomycosis is a chronic, progressive granulomatous fungal infection of the cutaneous and subcutaneous tissues caused by traumatic transcutaneous inoculation of pigmented dematiaceous fungi, most commonly *Fonsecaea pedrosoi* or *Cladophialophora carrionii*
- who.int
It predominantly affects outdoor and agricultural laborers in tropical and subtropical climates, typically manifesting on exposed areas such as the extremities
- nih.gov
Clinically, it begins as an indolent erythematous macule or papule that evolves over months to years into polymorphic verrucous plaques, nodular lesions, or cauliflower-like tumoral masses prone to ulceration, secondary bacterial infection, and scarring
- nih.gov
Pathophysiologically, the disease is defined by suppurative granulomatous inflammation and microabscess formation, with histopathologic visualization of characteristic thick-walled, chestnut-brown muriform cells (sclerotic bodies) within tissue
- oup.com
Pathophysiologically, the disease is defined by suppurative granulomatous inflammation and microabscess formation, with histopathologic visualization of characteristic thick-walled, chestnut-brown muriform cells (sclerotic bodies) within tissue
Personalize your experience
Follow Chromoblastomycosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.